Gail Cawkwell - Jun 27, 2022 Form 3 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Role: Chief Medical Officer
Signature: /s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol: ACRS
Transactions as of: Jun 27, 2022
Transactions value $: $0
Form type: 3
Date filed: 7/5/2022, 04:54 PM
Previous filing: Feb 15, 2022
Next filing: Jul 5, 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24.1 - Power of Attorney